Evidence map›Paper›PMID 10050887›Full record

ArticleOncogene1999

Nuclear and nucleolar targeting of human ribosomal protein S25: common features shared with HIV-1 regulatory proteins.

S Kubota, T D Copeland, R J Pomerantz

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The nucleolus and viral infection.Virologica Sinica · 2010
    Review
  8. Article
  9. Article
  10. RNA viruses: hijacking the dynamic nucleolus.Nature reviews. Microbiology · 2007
    Review
  11. Article
  12. The moving parts of the nucleolus.Histochemistry and cell biology · 2005
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S KubotaCenter for Human Virology, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
T D Copeland
R J Pomerantz
Thomas Jefferson University · USCancer Research Center · US

Funding

INTRACELLULAR ANTIBODIES AND HIV 1R01AI036552 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI POMERANTZ, ROGER J · 1994 to 1997
–
NIAID NIH HHS AI36552
6 · The paper itself

Abstract

The nuclear and nucleolar targeting properties of human ribosomal protein S25 (RPS25) were analysed by the expression of epitope-tagged RPS25 cDNAs in Cos-1 cells. The tagged RPS25 was localized to the cell nucleus, with a strong predominance in the nucleolus. At the amino terminus of RPS25, two stretches of highly basic residues juxtapose. This configuration shares common features with the nucleolar targeting signals (NOS) of lentiviral RNA-binding transactivators, including human immunodeficiency viruses' (HIV) Rev proteins. Deletion and site-directed mutational analyses demonstrated that the first NOS-like stretch is dispensable for both nuclear and nucleolar localization of RPS25, and that the nuclear targeting signal is located within the second NOS-like stretch. It has also been suggested that a set of continuous basic residues and the total number of basic residues should be required for nucleolar targeting. Signal-mediated nuclear/nucleolar targeting was further characterized by the construction and expression of a variety of chimeric constructs, utilizing three different backbones with RPS25 cDNA fragments. Immunofluorescence analyses demonstrated a 17 residue peptide of RPS25 as a potential nuclear/nucleolar targeting signal. The identified peptide signal may belong to a putative subclass of NOS, characterized by compact structure, together with lentiviral RNA-binding transactivators.

Indexed as

Nuclear Localization SignalsAnimalsCell Line, TransformedCell NucleolusCell NucleusCOS CellsEpitopes, B-LymphocyteGene ExpressionGene Products, revHIV-1HumansOligopeptidesPeptidesRecombinant Fusion Proteinsrev Gene Products, Human Immunodeficiency VirusRibosomal ProteinsEpitopes, B-LymphocyteFLAG peptideGene Products, revNuclear Localization SignalsOligopeptidesPeptidesRecombinant Fusion Proteinsrev Gene Products, Human Immunodeficiency VirusRibosomal ProteinsRPS25 protein, human

Identifiers

PMID10050887
OpenAlexW2317004469

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.